Are Capillary Whole Blood Coagulation Monitors Suitable for the Control of Oral Anticoagulant Treatment by the International Normalized Ratio?

Summary

The 512 Coagulation Monitor is a portable coagulation photometer that uses disposable cartridges containing a lyophilized rabbit brain thromboplastin to measure the PT for capillary whole blood. It has been proposed as a suitable system for patient self monitoring at home, but its performance has never been thoroughly assessed for results expressed as International Normalized Ratio (INR). In particular, there is no available information about the adequacy of the WHO calibration model with the Monitor. The aims of the study were to determine the International Sensitivity Index (ISI) against the secondary International Reference Preparation for rabbit thromboplastin and to assess the precision of the INR. The study demonstrates that the Monitor can be calibrated with the WHO model, because log-transformed PTs for patients stabilized on oral anticoagulants and normal individuals are linearly related and because the same orthogonal regression line describes patient and normal data points adequately. However, the ISI calculated in this study (2.715) is higher than that adopted by the manufacturer (2.036). The between-assay reproducibility of the Monitor is acceptable (CV = 9.7%) with results expressed in seconds, but become unacceptably poor when the results are converted into INR (CV = 18.8%) because of the high ISI value of the thromboplastin used. We think that the Monitor might be suitable for monitoring oral anticoagulant therapy if the manufacturer would provide a more sensitive thromboplastin in the cartridges.

• References

• 1 Dalen JE, Hirsh J. American College of Chest Physicians and National Heart Lung and Blood Institute National Conference on Antithrombotic Therapy. Arch Intern Med 1986; 146: 462-472
• 2 Levine MN, Hirsh J. Hemorrhagic complications of anticoagulant therapy. Sem Thrombos Haemostas 1986; 12: 39-57
• 3 Hull R, Hirsh J, Jay R, Carter G, England C, Gent M, Turpie AGG, McLoughlin D, Dodd P, Thomas M, Raskob G, Ockelford P. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. New Engl J Med 1982; 307: 1676-1681
• 4 Poller L. Therapeutic ranges in anticoagulant administration. Brit Med J 1985; 290: 1683-1686
• 5 British Society of Haematology. Guidelines on oral anticoagulation. Second edition J Clin Path 1990; 43: 177-183
• 6 Lucas FV, Duncan A, Jay R, Coleman R, Craft P, Chan B, Winfrey L, Mungall DR, Hirsh J. A novel whole blood capillary technic for measuring the prothrombin time. Am J Clin Pathol 1987; 88: 442-426
• 7 International Committee for Standardization in Haematology and International Committee on Thrombosis and Haemostasis. ICSH/ ICTH recommendations for reporting prothrombin time in oral anticoagulant control. Thrombos Haemostas 1985; 53: 155-156
• 8 Community Bureau of Reference-BCR. Recommended methodology for using BCR thromboplastin RMs. Available from BCR, rue de la Loi, B-1049 Brussels. Belgium:
• 9 World Health Organization. Recommended methodology for using WHO International Reference Preparations for thromboplastins. Available from World Health Organization, CH-1211 Geneva 27. Switzerland:
• 10 van denBesselaar AMHP, Bertina RM. Multicenter calibration of the Second Reference Material for thromboplastin, rabbit, plain, coded CRM 149R. Thrombos Haemostas 1991; 65: 263-267
• 11 Poller L, Thomson JM, Yees KF. Automated versus manual techniques for the prothrombin time test: Results of proficiency assessment studies. Br J Haematol 1978; 38: 391-399
• 12 van denBesselaar AMHP, Evatt BL, Brogan DR, Triplett DA. Proficiency testing and standardization of prothrombin time: effect of thromboplastin, instrumentation, and plasma. Am J Clin Pathol 1984; 82: 688-699
• 13 Evatt BL, Brogan D, Triplett DA, Koepke J, Waters G. Effect of thromboplastin and instrumentation on the prothrombin time test. Clin Lab Haematol 1981; 3: 331-342
• 14 Chantarangkul V, Tripodi A, Mannucci PM. The effect of instrumentation on thromboplastin calibration. Thrombos Haemostas 1992; 67: 588-589
• 15 Hirsh J, Levine M. Confusion over therapeutic range for monitoring oral anticoagulant therapy in North America. Thrombos Haemostas 1988; 59: 129-132
• 16 Palareti G, Coccheri S, Poggi M, Bonetti M, Cervi V, Mazzucca A, Savoia M, Veri L, Fiori F, Gaspari G, Palareti A. Oral anticoagulant control: Evidence that INR expression improves the inter-laboratory comparability of results The Bologna oral anticoagulant control exercise. Thrombos Haemostas 1987; 58: 905-910
• 17 Thromboplastin calibration and oral anticoagulant control. van denBesselaar AMHP, Gralnick HR, Lewis SM. (eds). Boston, MA: Martinus Nijhoff Publisher; 1984
• 18 WHO Expert Committee on Biological Standardization. Thirty-third Report. WHO Tech Rep Ser 1983; 687: 081-105
• 19 Tripodi A, Arbini AA, Chantarangkul V, Mannucci PM. Recombinant tissue factor as substitute for conventional thromboplastin in the prothrombin time test. Thrombos Haemostas 1992; 67: 42-45
• 20 Millenson MM, Bauer KA, Kistler JP, Barzegar S, Tulin L, Rosenberg RD. Monitoring “mini intensity” anticoagulation with warfarin: comparison of the prothrombin time using a sensitive thromboplastin with prothrombin fragment F 1 + 2 levels. Blood 1992; 79: 2034-2038
• 21 Taberner DA, Poller L, Thomson JM, Darby KV. Effect of international sensitivity index (ISI) of thromboplastins on precision of international normalized ratios (INR). J Clin Path 1989; 42: 92-96
• 22 van denBesselaar AMHP, Bertina RM. Multi-center study of thromboplastin calibration. Precision-influence of reagent species, composition, and international sensitivity index (ISI). Thrombos Haemostas 1993; 69: 35-40
• 23 Ansell J, Holden A, Knapic RN. Patients self-management of oral anticoagulation guided by a capillary (fingerstick) whole blood prothrombin times. Arch Intern Med 1989; 149: 2509-2511
• 24 Jennings I, Luddington RJ, Baglin T. Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulation. J Clin Pathol 1991; 44: 950-953
• 25 Weibert RT, Adler DS. Evaluation of a capillary whole-blood prothrombin time measurement system. Clin Pharm 1989; 8: 864-867
• 26 White RH, McCurdy SA, Von MarensdorffH, Woodruff Jr DE, Leftgoff L. Home prothrombin time monitoring after initiation of warfarin therapy. Ann Int Med 1989; 111: 730-737